Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11542225 Lipids for use in lipid nanoparticle formulations

Patent 11542225 was granted and assigned to Acuitas Therapeutics on January, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Acuitas Therapeutics

Current Assignee

Acuitas Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

January 3, 2023

Patent Application Number

16638728

Date Filed

August 17, 2018

Patent Citations

US Patent 10723692 Lipids and lipid nanoparticle formulations for delivery of nucleic acids

US Patent 11040112 Lipids and lipid nanoparticle formulations for delivery of nucleic acids

US Patent 11357856 Lipids for delivery of active agents

US Patent 11168051 Lipids and lipid nanoparticle formulations for delivery of nucleic acids

US Patent 10106490 Lipids and lipid nanoparticle formulations for delivery of nucleic acids

US Patent 10144725 Amine cationic lipids and uses thereof

US Patent 10166298 Lipids and lipid nanoparticle formulations for delivery of nucleic acids

US Patent 10221127 Lipids and lipid nanoparticle formulations for delivery of nucleic acids

...

Patent Citations Received

US Patent 12129223 Lipids for use in lipid nanoparticle formulations

0

US Patent 12065396 Lipids for use in lipid nanoparticle formulations

0

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11542225 Lipids for use in lipid nanoparticle formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool